Aberrant epigenetic regulation: a central contributor to lung carcinogenesis and a new therapeutic target. [electronic resource]
Producer: 20151103ISSN:- 1548-8756
- Animals
- Antineoplastic Agents -- therapeutic use
- Biomarkers, Tumor -- genetics
- Cell Transformation, Neoplastic -- genetics
- Drug Design
- Epigenesis, Genetic -- drug effects
- Gene Expression Regulation, Neoplastic
- Genetic Predisposition to Disease
- Humans
- Lung Neoplasms -- drug therapy
- Molecular Targeted Therapy
- Phenotype
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review; Video-Audio Media
There are no comments on this title.
Log in to your account to post a comment.